Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

289 Press Releases
DateTitleCompany
30 Sep 16 Takeda Announces Winners From Its Depression Care Challenge Competition Takeda ,
Published by
PharmiWeb.com
21 Sep 16 Takeda and Affilogic enter into Research Collaboration to Develop Nanofitin®-based Therapies in Central Nervous System Takeda Pharmaceutical Company Limited,
Published by
Business Wire
20 Sep 16 Takeda and Zydus Cadila partner to address the global threat of Chikungunya Takeda Pharmaceutical Company Limited,
Published by
Business Wire
19 Sep 16 Takeda Receives Positive CHMP Opinion for Conditional Approval of NINLAROTM (ixazomib), the First Oral Proteasome Inhibitor, for Use in Patients with Multiple Myeloma Takeda ,
Published by
PharmiWeb.com
16 Sep 16 Takeda Receives Positive CHMP Opinion for Conditional Approval of NINLAROTM (ixazomib), the First Oral Proteasome Inhibitor, for Use in Patients with Multiple Myeloma Takeda Pharmaceutical Company Limited,
Published by
Business Wire
13 Sep 16 Takeda Supports Global Expansion of the American Cancer Society's Relay For Life (RFL) Takeda ,
Published by
PharmiWeb.com
13 Sep 16 Takeda Supports Global Expansion of the American Cancer Society’s Relay For Life (RFL) Takeda ,
Published by
PharmiWeb.com
01 Sep 16 Takeda to develop Zika Vaccine with up to $312 million in funding from US Government Takeda Pharmaceutical Company Limited,
Published by
Business Wire
31 Aug 16 Takeda Launches Largest Pharmaceutical Company-Sponsored Global Observational Study of Its Kind in Multiple Myeloma Takeda Pharmaceutical Company Limited,
Published by
Business Wire
27 Aug 16 Takeda Announces Bold, New Access to Medicines Strategy Takeda ,
Published by
PharmiWeb.com
26 Aug 16 Takeda Announces Bold, New Access to Medicines Strategy Takeda Pharmaceutical Company Limited,
Published by
Business Wire
08 Aug 16 Takeda Receives Marketing Authorization in Canada for NINLARO™ (ixazomib) in Relapsed/Refractory Multiple Myeloma Takeda Pharmaceutical Company Limited,
Published by
Business Wire
02 Aug 16 Takeda and TiGenix Announce Publication in The Lancet of 24-Week Results of the Phase 3 ADMIRE-CD Trial Investigating Cx601 in the Treatment of Complex Perianal Fistulas in Patients with Crohn's Disease Takeda Pharmaceutical Company Limited,
Published by
PR Newswire
29 Jul 16 Takeda Reports 1st Quarter 2016 Results with a Strong Start to the Year and Confidence in Management Guidance Takeda Pharmaceutical Company Limited,
Published by
Business Wire
13 Jul 16 Takeda and the Crohn's & Colitis Foundation of America Partner to Introduce 'IBD Unmasked' A First-of-its-Kind Awareness Campaign Takeda Pharmaceuticals U.S.A., Inc.,
Published by
PR Newswire
13 Jul 16 IBD Unmasked, a First-of-its-Kind Global Awareness Initiative, Launches to Support and Empower the Inflammatory Bowel Disease Community Takeda Pharmaceutical Company Limited,
Published by
PR Newswire
05 Jul 16 Takeda Submits a New Drug Application for Novel, Oral Proteasome Inhibitor Ixazomib in Japan Takeda Pharmaceutical Company Limited,
Published by
Business Wire
05 Jul 16 Takeda and TiGenix Enter into Licensing Agreement for Ex-U.S. Rights to Cx601 for the Treatment of Complex Perianal Fistulas in Patients with Crohn's Disease Takeda Pharmaceutical Company Limited,
Published by
PR Newswire
27 May 16 Takeda Provides Update on EU Marketing Authorization Application for NINLARO® (ixazomib) in Relapsed/Refractory Multiple Myeloma Takeda Pharmaceutical Company Limited,
Published by
Business Wire
27 May 16 Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) as Consolidation Treatment in Post-Transplant Hodgkin Lymphoma Takeda Pharmaceutical Company Limited,
Published by
Business Wire
15 Jun 16 EXAMINE Trial Post-Hoc Analyses of Mortality Data Regarding Cardiovascular Safety of Alogliptin Presented at American Diabetes Association's 76th Scientific Sessions and Published in Diabetes Care Takeda Pharmaceutical Company Limited
12 May 16 Takeda Appoints New Chief Financial Officer, James Kehoe Takeda Pharmaceutical Company Limited,
Published by
Business Wire
01 Jun 16 Trintellix (vortioxetine) Now Available in U.S. Pharmacies Takeda Pharmaceuticals U.S.A., Inc.,
Published by
PR Newswire
16 Jun 16 Tri-Institutional Therapeutics Discovery Institute, Inc. Expands Partnership with Takeda Pharmaceutical Company, Ltd. Takeda Pharmaceutical Company, Ltd.,
Published by
Business Wire
22 Jun 16 TB Alliance and Takeda Announce Advancement of Joint Program Investigating Promising Compounds for Novel TB Therapies Through Global Health Innovative Technology Fund Takeda Pharmaceutical Company Limited,
Published by
Business Wire
01 Jul 16 Takeda to Partner with Altos Therapeutics to Develop Promising Compound for the Treatment of Gastroparesis Takeda Pharmaceutical Company Limited,
Published by
Business Wire
16 May 16 Takeda and Lundbeck Present Vortioxetine Data at the American Psychiatric Association (APA) 2016 Annual Meeting Takeda Pharmaceuticals U.S.A., Inc.,
Published by
PR Newswire
20 Jun 16 Takeda Initiates World’s First Norovirus Vaccine Field Trial Takeda Pharmaceutical Company Limited,
Published by
Business Wire
09 May 16 Takeda Receives $38 Million Grant from the Bill & Melinda Gates Foundation to Support Polio Eradication in Developing Countries Takeda Pharmaceutical Company Limited,
Published by
Business Wire
17 Jun 16 Takeda and M2Gen Collaborate with ORIEN to Speed Clinical Development and Discovery of Cancer Treatments Through Health Informatics Takeda ,
Published by
PharmiWeb.com
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.